Literature DB >> 6539421

Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.

P R Kowey, R Eisenberg, T R Engel.   

Abstract

Patients with hypertrophic obstructive cardiomyopathy are subject to syncope and sudden death. Ambulatory monitoring discloses frequent and complex ventricular ectopy in many of these patients, and the occurrence of ventricular tachycardia suggests an increased risk of sudden death. We prospectively evaluated whether induced sustained arrhythmia could explain episodes of cerebral dysfunction in hypertrophic cardiomyopathy. Seven consecutive symptomatic patients (six of whom had an intraventricular gradient of 40 to 130 mm Hg) were subjected to atrial and ventricular stimulation. An electrophysiologic abnormality that would explain the symptoms was identified in every patient: supraventricular tachycardia was present in two, sustained ventricular tachycardia in three, ventricular fibrillation in one, and a prolonged QT interval and dispersion of ventricular refractoriness in one. Antiarrhythmic drugs were selected on the basis of the response to electrophysiologic testing. There has been no recurrence of symptoms in 120 patient-months of follow-up. This experience suggests that arrhythmias are the principal cause of syncope or sudden death in obstructive cardiomyopathy and that electrophysiologic study may be useful in selecting prophylactic therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539421     DOI: 10.1056/NEJM198406143102405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  5 in total

1.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

2.  Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm.

Authors:  F Alfonso; M P Frenneaux; W J McKenna
Journal:  Br Heart J       Date:  1989-02

3.  Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; F Cecchi; W J McKenna
Journal:  Br Heart J       Date:  1994-12

Review 4.  Management of arrhythmias in hypertrophic cardiomyopathy.

Authors:  J T Stewart; W J McKenna
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

5.  Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy.

Authors:  X Jouven; A Hagege; P Charron; L Carrier; O Dubourg; J M Langlard; S Aliaga; J B Bouhour; K Schwartz; M Desnos; M Komajda
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.